IceCure Medical Ltd. — Proxy Solicitation & Information Statement 2026

Apr 22, 2026

6-K 1 ea0287198-01.htm CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

_____

Form 6-K

_____

Report of Foreign Private Issuer Pursuant to Rule 13a -16 or 15d -16 under the Securities Exchange Act of 1934

For the month of April 2026 (Report No. 2)

Commission File Number: 001 -40753

_____

ICECURE MEDICAL Ltd. (Translation of registrant’s name into English)

_____

7 Ha’Eshel St., PO Box 3163 Caesarea, 3079504 Israel (Address of principal executive offices)

_____

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20 -F or Form 40 -F .

Form 20 -F ☒ Form 40 -F ☐

CONTENTS

Attached hereto and incorporated herein are the Notice of Meeting, Proxy Statement and Form of Proxy Card for the Special General Meeting of Shareholders of IceCure Medical Ltd. (the “Company”) to be held on Monday, May 11, 2026 (the “Meeting”).

Only shareholders of record who hold Ordinary Shares, no par value, of the Company at the close of business on Monday, April 27, 2026, will be entitled to notice of and to vote at the Meeting and any postponements or adjournments thereof.

Copies of the Notice of Special General Meeting, Proxy Statement and Form of Proxy Card for the Meeting are furnished herewith as Exhibits 99.1, 99.2 and 99.3, respectively.

This Report of Foreign Private Issuer on Form 6 -K is incorporated by reference into the Company’s Registration Statements on Form F -3 (File Nos. 333 -290046 and 333 -258660 ) and Form S -8 (File Nos. 333 -270982 , 333 -264578 , 333 -262620 and 333 -281587 ), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6 -K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

1

EXHIBIT INDEX

Exhibits No.
99.1	Notice for the Special General Meeting of Shareholders to be held on May 11, 2026.
99.2	Proxy Statement for the Special General Meeting of Shareholders to be held on May 11, 2026.
99.3	Form of Proxy Card for the Special General Meeting of Shareholders to be held on May 11, 2026.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

IceCure Medical Ltd. — By:	/s/ Eyal Shamir
Name:	Eyal Shamir
Title:	Chief Executive Officer

3